APS
29th APS Annual Convention
Understanding and Managing Distress with Cannabis: Neuropsychiatric Comorbidity and Targets for Treatment
Cannabis is used for medicinal purposes but is also linked to neuropsychiatric problems, and this risk/benefit issue remains unresolved. This symposium will broaden the understanding of the relationships between cannabis, neuropsychiatric symptoms and mental illness, and discuss the utility of a cognitive target for intervention for problematic cannabis use.
Chairs & Discussants
- Nehal VadhanChair
Hofstra/Northwell - Nehal VadhanChair
Northwell Health - Staci GruberCoChair
Harvard Medical School - Staci GruberCoChair
McLean Hospital - Alan BudneyDiscussant
Geisel School of Medicine at Dartmouth College
Presentations
- Potential Mechanisms of Differential Response to Smoked Cannabis in Individuals at Clinical High-Risk for PsychosisNehal Vadhan
- Let’s be Blunt: Exploring the Impact of Recreational and Medical Cannabis UseStaci Gruber
- The Mediating Roles of Sleep and Coping Motives in Cannabis Use and Problems Among Returning Veterans with Posttraumatic Stress and Major Depressive DisordersJane Metrik
- Examining Cognitive Bias Modification As a Potential Treatment for Cannabis-Using YouthLindsay Squeglia